UBS Maintains Neutral on eHealth, Lowers Price Target to $1.75

Benzinga · 2d ago
UBS analyst Jonathan Yong maintains eHealth (NASDAQ:EHTH) with a Neutral and lowers the price target from $2 to $1.75.